Stay updated on Nivolumab for Recurrent Rare CNS Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.

Latest updates to the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedA new site revision tag 'Revision: v3.4.2' was added. The deletions remove an operating-status notice and a prior revision tag ('Revision: v3.4.1'), which are administrative updates and do not change study content.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's status, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedUI and metadata updates are minor: a glossary toggle is now shown, the Last Update Submitted that Met QC Criteria label is displayed, a No FEAR Act Data link is included, and the site revision is updated to v3.4.0 (from v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedMinor revision from v3.3.3 to v3.3.4 with no detectable changes to study content or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a top-level Locations section listing Illinois, Maryland, and Texas, and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.4%

- Check92 days agoChange DetectedRevision: v3.2.0 updated to v3.3.2; no substantive changes to study content or layout detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab for Recurrent Rare CNS Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.